271 related articles for article (PubMed ID: 29232552)
1. Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy.
Zheng H; Bae Y; Kasimir-Bauer S; Tang R; Chen J; Ren G; Yuan M; Esposito M; Li W; Wei Y; Shen M; Zhang L; Tupitsyn N; Pantel K; King C; Sun J; Moriguchi J; Jun HT; Coxon A; Lee B; Kang Y
Cancer Cell; 2017 Dec; 32(6):731-747.e6. PubMed ID: 29232552
[TBL] [Abstract][Full Text] [Related]
2. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
3. Breaking Down Barriers to Chemoresistance: Role of Chemotherapy-Induced Osteoblastic Jagged1.
Mohammad KS; Guise TA
Cancer Cell; 2017 Dec; 32(6):717-718. PubMed ID: 29232546
[TBL] [Abstract][Full Text] [Related]
4. The Notch Ligand Jagged1 Regulates the Osteoblastic Lineage by Maintaining the Osteoprogenitor Pool.
Lawal RA; Zhou X; Batey K; Hoffman CM; Georger MA; Radtke F; Hilton MJ; Xing L; Frisch BJ; Calvi LM
J Bone Miner Res; 2017 Jun; 32(6):1320-1331. PubMed ID: 28277610
[TBL] [Abstract][Full Text] [Related]
5. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
Haider MT; Holen I; Dear TN; Hunter K; Brown HK
Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
[TBL] [Abstract][Full Text] [Related]
6. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.
Zhang Z; Wang H; Ikeda S; Fahey F; Bielenberg D; Smits P; Hauschka PV
Am J Pathol; 2010 Sep; 177(3):1459-69. PubMed ID: 20651241
[TBL] [Abstract][Full Text] [Related]
7. Current trials using bone-targeting agents in prostate cancer.
Tu SM; Lin SH
Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells.
Weber JM; Forsythe SR; Christianson CA; Frisch BJ; Gigliotti BJ; Jordan CT; Milner LA; Guzman ML; Calvi LM
Bone; 2006 Sep; 39(3):485-93. PubMed ID: 16647886
[TBL] [Abstract][Full Text] [Related]
9. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
[TBL] [Abstract][Full Text] [Related]
10. Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas.
Bednarz-Knoll N; Efstathiou A; Gotzhein F; Wikman H; Mueller V; Kang Y; Pantel K
Clin Chem; 2016 Feb; 62(2):378-86. PubMed ID: 26721293
[TBL] [Abstract][Full Text] [Related]
11. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
Lee YP; Schwarz EM; Davies M; Jo M; Gates J; Zhang X; Wu J; Lieberman JR
Cancer Res; 2002 Oct; 62(19):5564-70. PubMed ID: 12359769
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
[TBL] [Abstract][Full Text] [Related]
13. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
[TBL] [Abstract][Full Text] [Related]
14. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.
Yamaguchi M; Zhu S; Zhang S; Wu D; Moore TM; Snyder JP; Shoji M
Cell Tissue Res; 2014 Jul; 357(1):245-52. PubMed ID: 24723227
[TBL] [Abstract][Full Text] [Related]
15. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
Steg AD; Katre AA; Goodman B; Han HD; Nick AM; Stone RL; Coleman RL; Alvarez RD; Lopez-Berestein G; Sood AK; Landen CN
Clin Cancer Res; 2011 Sep; 17(17):5674-85. PubMed ID: 21753153
[TBL] [Abstract][Full Text] [Related]
16. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
17. A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
Otsuka S; Hanibuchi M; Ikuta K; Yano S; Goto H; Ogino H; Yamada T; Kakiuchi S; Nishioka Y; Takahashi T; Sone S
Oncol Res; 2009; 17(11-12):581-91. PubMed ID: 19806789
[TBL] [Abstract][Full Text] [Related]
18. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.
Suominen MI; Rissanen JP; Käkönen R; Fagerlund KM; Alhoniemi E; Mumberg D; Ziegelbauer K; Halleen JM; Käkönen SM; Scholz A
J Natl Cancer Inst; 2013 Jun; 105(12):908-16. PubMed ID: 23682134
[TBL] [Abstract][Full Text] [Related]
20. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]